File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Enterococcus cecorum Empyema Thoracis Successfully Treated with Cefotaxime
  • Basic View
  • Metadata View
  • XML View
TitleEnterococcus cecorum Empyema Thoracis Successfully Treated with Cefotaxime
 
AuthorsWoo, PCY1
Tam, DMW1
Lau, SKP1
Fung, AMY1
Yuen, KY1
 
Issue Date2004
 
PublisherAmerican Society for Microbiology.
 
CitationJournal Of Clinical Microbiology, 2004, v. 42 n. 2, p. 919-922 [How to Cite?]
DOI: http://dx.doi.org/10.1128/JCM.42.2.919-922.2004
 
AbstractWe report the first case of Enterococcus cecorum empyema thoracis and spontaneous bacterial peritonitis in a 44-year-old man with underlying cirrhosis. The patient responded to cefotaxime (MIC, 0.25 μg/ml) treatment and drainage of the empyema. Susceptibility of E. cecorum to expanded-spectrum cephalosporins could be due to its production of types of penicillin-binding proteins similar to those produced by Streptococcus species rather than to those produced by Enterococcus species (as predicted by phylogenetic analysis of the 16S rRNA gene sequences).
 
ISSN0095-1137
2012 Impact Factor: 4.068
2012 SCImago Journal Rankings: 1.785
 
DOIhttp://dx.doi.org/10.1128/JCM.42.2.919-922.2004
 
PubMed Central IDPMC344503
 
ISI Accession Number IDWOS:000189379000086
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorWoo, PCY
 
dc.contributor.authorTam, DMW
 
dc.contributor.authorLau, SKP
 
dc.contributor.authorFung, AMY
 
dc.contributor.authorYuen, KY
 
dc.date.accessioned2008-06-12T06:37:28Z
 
dc.date.available2008-06-12T06:37:28Z
 
dc.date.issued2004
 
dc.description.abstractWe report the first case of Enterococcus cecorum empyema thoracis and spontaneous bacterial peritonitis in a 44-year-old man with underlying cirrhosis. The patient responded to cefotaxime (MIC, 0.25 μg/ml) treatment and drainage of the empyema. Susceptibility of E. cecorum to expanded-spectrum cephalosporins could be due to its production of types of penicillin-binding proteins similar to those produced by Streptococcus species rather than to those produced by Enterococcus species (as predicted by phylogenetic analysis of the 16S rRNA gene sequences).
 
dc.description.naturepublished_or_final_version
 
dc.format.extent386 bytes
 
dc.format.mimetypetext/html
 
dc.identifier.citationJournal Of Clinical Microbiology, 2004, v. 42 n. 2, p. 919-922 [How to Cite?]
DOI: http://dx.doi.org/10.1128/JCM.42.2.919-922.2004
 
dc.identifier.doihttp://dx.doi.org/10.1128/JCM.42.2.919-922.2004
 
dc.identifier.epage922
 
dc.identifier.hkuros87957
 
dc.identifier.isiWOS:000189379000086
 
dc.identifier.issn0095-1137
2012 Impact Factor: 4.068
2012 SCImago Journal Rankings: 1.785
 
dc.identifier.issue2
 
dc.identifier.openurl
 
dc.identifier.pmcidPMC344503
 
dc.identifier.pmid14766891
 
dc.identifier.scopuseid_2-s2.0-1242269290
 
dc.identifier.spage919
 
dc.identifier.urihttp://hdl.handle.net/10722/49244
 
dc.identifier.volume42
 
dc.languageeng
 
dc.publisherAmerican Society for Microbiology.
 
dc.publisher.placeUnited States
 
dc.relation.ispartofJournal of Clinical Microbiology
 
dc.relation.referencesReferences in Scopus
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
 
dc.rightsJournal of Clinical Microbiology. Copyright © American Society for Microbiology.
 
dc.rightsCopyright © American Society for Microbiology, Journal of Clinical Microbiology, 2004, v. 42 n. 2, p. 919-922
 
dc.subject.meshAnti-Bacterial Agents - therapeutic use
 
dc.subject.meshCefotaxime - therapeutic use
 
dc.subject.meshEnterococcus - classification - drug effects - isolation & purification
 
dc.subject.meshGram-Positive Bacterial Infections - diagnosis - drug therapy
 
dc.subject.meshAsian Continental Ancestry Group
 
dc.titleEnterococcus cecorum Empyema Thoracis Successfully Treated with Cefotaxime
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Woo, PCY</contributor.author>
<contributor.author>Tam, DMW</contributor.author>
<contributor.author>Lau, SKP</contributor.author>
<contributor.author>Fung, AMY</contributor.author>
<contributor.author>Yuen, KY</contributor.author>
<date.accessioned>2008-06-12T06:37:28Z</date.accessioned>
<date.available>2008-06-12T06:37:28Z</date.available>
<date.issued>2004</date.issued>
<identifier.citation>Journal Of Clinical Microbiology, 2004, v. 42 n. 2, p. 919-922</identifier.citation>
<identifier.issn>0095-1137</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/49244</identifier.uri>
<description.abstract>We report the first case of Enterococcus cecorum empyema thoracis and spontaneous bacterial peritonitis in a 44-year-old man with underlying cirrhosis. The patient responded to cefotaxime (MIC, 0.25 &#956;g/ml) treatment and drainage of the empyema. Susceptibility of E. cecorum to expanded-spectrum cephalosporins could be due to its production of types of penicillin-binding proteins similar to those produced by Streptococcus species rather than to those produced by Enterococcus species (as predicted by phylogenetic analysis of the 16S rRNA gene sequences).</description.abstract>
<format.extent>386 bytes</format.extent>
<format.mimetype>text/html</format.mimetype>
<language>eng</language>
<publisher>American Society for Microbiology.</publisher>
<relation.ispartof>Journal of Clinical Microbiology</relation.ispartof>
<rights>Creative Commons: Attribution 3.0 Hong Kong License</rights>
<rights>Journal of Clinical Microbiology. Copyright &#169; American Society for Microbiology.</rights>
<rights>Copyright &#169; American Society for Microbiology, Journal of Clinical Microbiology, 2004, v. 42 n. 2, p. 919-922</rights>
<subject.mesh>Anti-Bacterial Agents - therapeutic use</subject.mesh>
<subject.mesh>Cefotaxime - therapeutic use</subject.mesh>
<subject.mesh>Enterococcus - classification - drug effects - isolation &amp; purification</subject.mesh>
<subject.mesh>Gram-Positive Bacterial Infections - diagnosis - drug therapy</subject.mesh>
<subject.mesh>Asian Continental Ancestry Group</subject.mesh>
<title>Enterococcus cecorum Empyema Thoracis Successfully Treated with Cefotaxime</title>
<type>Article</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=0095-1137&amp;volume=42&amp;issue=2&amp;spage=919&amp;epage=922&amp;date=2004&amp;atitle=Enterococcus+cecorum+empyema+thoracis+successfully+treated+with+cefotaxime</identifier.openurl>
<description.nature>published_or_final_version</description.nature>
<identifier.doi>10.1128/JCM.42.2.919-922.2004</identifier.doi>
<identifier.pmid>14766891</identifier.pmid>
<identifier.pmcid>PMC344503</identifier.pmcid>
<identifier.scopus>eid_2-s2.0-1242269290</identifier.scopus>
<identifier.hkuros>87957</identifier.hkuros>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-1242269290&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>42</identifier.volume>
<identifier.issue>2</identifier.issue>
<identifier.spage>919</identifier.spage>
<identifier.epage>922</identifier.epage>
<identifier.isi>WOS:000189379000086</identifier.isi>
<publisher.place>United States</publisher.place>
<bitstream.url>http://hub.hku.hk/bitstream/10722/49244/1/87957.htm</bitstream.url>
</item>
Author Affiliations
  1. The University of Hong Kong